Abstract: OBJECTIVES: Although intravoxel incoherent motion (IVIM) becomes more and more popular, there is currently no clear consensus on the number and distribution of b-values to use. In this work, we (1) tested and evaluated the data quality of a 25-b-value IVIM protocol in patients with malignant liver lesions and normal liver tissue as a standard of reference, (2) calculated an optimal b-value distribution and compared with the standard of reference, and (3) compared the 25-b-value protocol with other proposed protocols in the literature. MATERIALS AND METHODS: Intravoxel incoherent motion imaging with 25 b-values was performed at 3 T in a total of 15 patients with malignant liver lesions. Reference IVIM parameter maps were calculated in tumor and normal liver tissue. With these parameters, optimal IVIM protocols with reduced numbers of b-values were calculated. These optimal IVIM protocols were again applied to calculate new IVIM parameter maps that were compared with the reference parameter maps by calculating mean relative errors. In addition, 35 other IVIM protocols, as found in literature, were compared in a similar way with the 25-b-value protocol serving as a standard of reference. RESULTS: The mean relative error depends on the number of b-values and their distribution. In tumor tissue, the error is higher and more variable than in normal-appearing liver tissue. The largest errors occur in tumor tissue and in the protocols having low numbers of b-values in the IVIM protocols. In the calculated optimal IVIM protocols, the mean relative errors decreased by 40% or more when the number of b-values included increased from 4 to 16. The mean relative errors in the protocols adapted from the literature vary substantially between the various b-value distributions. One optimized 16-b-value protocol, which was found in literature, reduced the average relative error by 80% when compared with 4-and 5-b-value protocols listed in literature. CONCLUSIONS: Including more b-values and applying an optimized b-value distribution significantly reduces errors in the IVIM parameter estimates, thereby increasing its accuracy.This effect is even more pronounced in inhomogeneous tumor compared with that in normal liver tissue. However, when restrictions in acquisition time or patient-related factors apply, a minimum of 16 b-values should be considered for reliable results.
M agnetic resonance (MR) diffusion-weighted imaging (DWI) is a very successful and widely used functional imaging protocol providing information about the mobility of water molecules in tissue. By changing the amount of diffusion weighting, the b-value, it can be made more sensitive to smaller or larger displacements, such as, for example, in diffusion and perfusion, respectively.
Until recently, the DWI scan protocol was mainly applied to visualize the molecular water diffusion by scanning images with highdiffusion weighting (b-values >150 s/mm 2 ). The diffusion coefficient D, representing the true molecular water diffusion, can be obtained by fitting the b-values and corresponding measured data to a simple monoexponential diffusion model (Supplemental Digital Content 1, http://links.lww.com/RLI/A221). Because the diffusion is usually restricted in tissue, the diffusion coefficient is also known as the apparent diffusion coefficient.
Where "conventional" DWI is a method to visualize the molecular water diffusion only, intravoxel incoherent motion (IVIM) imaging is a method to visualize both the molecular water diffusion and the information about the microcirculation by using high and low b-values. The proposed biexponential IVIM model was described by Le Bihan et al 1, 2 :
where f is the fraction of the perfusion component and D* is the pseudodiffusion coefficient, related to perfusion in the microcirculation.
Intravoxel incoherent motion is becoming more and more popular in clinical research as it provides the additional perfusion information without the need of extensive changes in the MR acquisition protocols. [3] [4] [5] [6] The IVIM model is, however, less stable than the monoexponential diffusion model, as it requires the fitting of more variables.
One of the major concerns when implementing an IVIM protocol is the optimal number and distribution of b-values. In theory, 4 b-values would be sufficient to fit a biexponential function 7 ; however, including more b-values would make the fit process more robust and enables estimates of parameter uncertainties or quality. This could especially be important for reliable diagnoses and in cases where errors are expected due to, for example, noise, or patient, for example, respiratory and/or cardiac motion. 8, 9 Previously, other studies have investigated potentially optimal b-value distributions. [10] [11] [12] [13] [14] Lemke et al, 15 for example, performed Monte Carlo simulations to find the optimal b-value distributions in tissue with low (brain), medium (kidney), and high (liver) IVIM perfusion. However, in clinical cases, the chosen optimal b-value distributions may not perform as one would expect due to, for example, different IVIM parameter ranges in healthy and inhomogeneous tumor tissue.
The aims of this work were (1) to test and evaluate the data quality of a 25-b-value IVIM protocol in patients with malignant liver lesions and normal liver tissue as a standard of reference, (2) to calculate an optimal b-value distributions and compare to the standard of reference, and (3) to compare the 25-b-value protocol with other proposed protocols in the literature concerning data quality.
MATERIALS AND METHODS

Patients
Between September 2012 and January 2014, a total of 15 consecutive patients (mean age, 63 years; range, 33-88 years; 7 women, 8 men) with malignant liver lesions participated in this study. All included patients were referred clinically to our center for PET/CT for either staging or restaging/follow-up of various malignant tumors and volunteered to receive an additional MR imaging (MRI) examination. Exclusion criteria were contraindications to MRI, such as severe claustrophobia, and MRI-incompatible implants, such as cardiac pacemakers, insulin pumps, or neurostimulators. This prospective study was approved by the institutional review board and by the cantonal ethics committee. Signed informed consent was obtained from each patient before the inclusion into this study. Parts of this patient population have been evaluated in other studies in a different context.
Magnetic Resonance Imaging
All MRI examinations were performed on a 3.0-T whole-body MR system (Discovery 750w MR; GE Healthcare, Waukesha, WI) using the body coil for excitation and a posterior and anterior coil array for signal reception.
After conventional T 1 -and T 2 -weighted imaging, IVIM imaging was performed using a 2-dimensional diffusion-weighted spin-echo single-shot echo-planar imaging sequence covering 8 to 19 slices centered on the lesion of interest. Parallel imaging, array spatial sensitivity encoding technique, was applied to reduce image distortion.
Three different protocols, A, B, and C, were applied, but only 1 in each patient. The acquisition parameters are listed in Table 1 
Image Processing
Intravoxel incoherent motion parameter maps were calculated by voxelwise fitting the model of equation 1 to the measured, 25 b-values, data using Matlab 2013b (MathWorks, Natick, MA). The applied method is a nonlinear least squares fit using a trust region algorithm. 16 The IVIM parameters f, D, and D* were allowed to vary in the reference ranges found in liver and tumors. The boundaries were set to 1.0 Â 10 In addition, ROIs with a diameter of approximately 30 mm were drawn in normal-appearing liver tissue, avoiding large vessels and ducts. The ROIs were copied to the IVIM parameter maps, and the voxel values for f, D, and D* were extracted to calculate arithmetic means for every ROI. The ROIs were grouped according to tumor or normal tissue type and the minimal; maximal as well as the arithmetic mean and standard deviation were calculated for all IVIM parameters for each group.
Calculation of Optimal b-Value Distributions
Reducing the number of diffusion weightings reduces scan time, patient discomfort, and finally acquisition costs. Therefore, new b-value distributions with less than 25 b-values were calculated to find optimal distributions with less b-values and results comparable to the 25-b-value distribution. To find these optimal b-value distributions, the b-values that minimized the error propagation factor ε for the biexponential model were selected. The error propagation factor was calculated in a similar way as described by Zhang et al 12 (Supplemental Digital Content 2, http://links.lww.com/RLI/A222). The previously 
Error Calculations
The calculated optimal b-value distributions, the mapped b-value distributions from literature, and their corresponding measured signals were used to calculate new IVIM parameter maps by fitting the model of Equation 1 to the data, in the same way as described before with the 25-b-value distribution. The f, D, and D* voxel values in the ROIs were again extracted and compared with the values that were previously calculated using the 25-b-value distribution. The relative mean absolute error γ in each ROI was then calculated with: The calculated relative errors were grouped together according to tissue type and number of b-values or literature protocols, and arithmetic means and standard deviations were calculated for each group.
RESULTS
In protocol group A, 4 patients were scanned. One patient had no or very small tumors (<15 mm diameter) and was excluded for the lesion analysis. One patient was included after radiotherapy and had 2 metastases from melanoma that were both included. The 2 other patients had lesions from breast cancer and a metastatic melanoma without treatment. In protocol group B, 5 patients were scanned. One patient had 2 very large colon metastases in the liver and was excluded for the normal liver tissue analysis as no large enough region could be identified as normal liver. Two patients had no or very small tumors (<15 mm diameter), and 1 patient had motion artifacts; all were excluded for the lesion analysis. One patient had 2 metastases from primary bronchial lung carcinoma, and both were included. In protocol group C, 6 patients were scanned. Two patients had no or very small tumors (<15 mm diameter), and 1 patient had motion artifacts; all were excluded for the lesion analysis. The other 3 patients had metastases from primary cholangiocarcinoma, colon cancer, and pancreatic cancer. Of these, the first patient was scanned before therapy, the latter 2 after chemotherapy.
Overall, 14 ROIs (median size, 277 voxels; range, 277-807 voxels) of normal liver tissue and 11 ROIs (median size, 422 voxels; range, 50-4624 voxels) within malignant liver lesions were evaluated.
Examples of the IVIM parameter maps are shown in Figure 1 . Differences in the perfusion fraction (f), the pseudodiffusion (D*), and the diffusion (D) maps, when calculated with 4-, 9-, and 25-b-value distributions, can clearly be appreciated.
The minimal, maximal, arithmetic mean, and standard deviation for f, D, and D* in tumor and normal liver tissue, calculated with the 25-b-value data sets, are listed in Table 2 .
Calculation of Optimal b-Value Distributions
Optimal parameter distributions for the 3 protocols A, B, and C were calculated by inserting the previously evaluated minimal and maximal values for f, D, and D* (Table 2) Table 3 .
These optimal parameter distributions were tested by calculating the relative errors γ, and the results are shown in Figure 2 
Distributions of b-Values in Literature and Comparison
The mean relative errors for the modified and mapped b-value distributions by Lemke et al, 15 shown in Figure 3 The mean relative errors in the protocols adapted from the literature (Fig. 4) vary substantially between the various b-value distributions. The mapped 11-b-value distribution by Leporq et al 21 performs clearly better than the mapped 9-b-value distribution by Klauss et al, 26 whereas the 6 b-values between 100 and 800 s/mm 2 are the same in both cases. The differences are mainly found in the lower b-value range where the former has 2 more b-values. The protocols by Hiepe et al 19 and Ichikawa et al 20 have a relative higher number of low b-values (<100 s/mm 2 ). These protocols also have lower errors in the pseudoperfusion D*.
19,20
The 16-b-value distribution by Wurnig et al, 17 which is taking into account the findings of Lemke et al, 15 Figure 4 also shows that, on average, the mean relative error is larger in liver tumor tissue compared with that in normal liver tissue for f and D*, whereas for D, the mean relative error is larger in normal liver tissue.
DISCUSSION
Although IVIM becomes more and more popular, there is currently no clear consensus on the number and distribution of b-values to use. In this study, we acquired a rather extensive 25-b-value IVIM protocol as a standard of reference to evaluate the data quality of other IVIM protocols having less b-values. The evaluation was performed for normal liver tissue and for malignant liver lesions. We showed that IVIM data quality improves significantly when the number of bvalues included in the protocol is increased, making IVIM modeling more robust.
The clinical role of IVIM is yet not completely defined, but there is certainly great potential in clinical routine applications. Because there is proof that multiparametric imaging can improve diagnostic accuracy, 32, 33 there is large interest to explore the possibilities of already available techniques, for example, diffusion sequences. Because IVIM is not only able to measure diffusion but also the microperfusion, it could provide additional information concerning the tumor's oxygenation status before therapy. This is important in scenarios where, for example, antiangiogenic therapy is planned or, vice versa, tumor perfusion is first therapeutically enhanced to ensure adequate delivery of chemotherapy to the tumor. However, before such therapy decisions can be based on imaging-derived parameters, it has to be ensured that data quality is sufficient, measurements are highly reliable, and patientbased influences are kept to a minimum.
Early IVIM studies usually evaluated a limited amount of up to 8 b-values and are likely chosen empirically. Having a limited number of b-values increases the risk of higher errors as, for example, 1 outlier already could have a large effect on the model fitting procedure and thus on the resulting IVIM parameters. Conversely, obtaining more than the minimal required 4 b-values for IVIM requires more scan time, and too extensive MR protocols may increase patient discomfort, which could again lead to patient motion and thus acquisition errors. Therefore, the clinically acceptable imaging time for IVIM was limited to 5 to 6 minutes in our study. In these 5 to 6 minutes, we were able to acquire a 25-b-value IVIM reference scan protocol. With these 25 b-values, we have significantly more data points available for the fitting procedure than the average 4-to 16-b-value IVIM protocols listed in literature. This allows us to use it as a reference in the comparison with other IVIM protocols.
Scanning an extensive 25-b-value IVIM protocol is not always desirable or even possible. For homogeneous tissue, when the expected IVIM parameter ranges are small and known beforehand, one could calculate and apply an optimal IVIM protocol with a reduced number of b-values and still would have sufficient data quality. A number of studies were dedicated on finding optimal b-value distributions: for example, Dyvorne et al 14 evaluated optimized b-value distributions in the liver for subjects enrolled in a liver fibrosis study. Although this study was also performed in the liver, the tissue properties (perfusion and diffusion) in tumors are different compared with that in (malignant) liver lesions. Jambor et al 13 Zhang et al 12 optimized the b-value sampling for a biexponential DWI model of the kidney, and Lemke et al 15 optimized the b-value distributions in tissue for low (brain), medium (kidney), and high (liver) IVIM perfusion. The studies by Jambor et al, Zhang et al, and Lemke et al were, however, validated in healthy volunteers. Tumorous tissue is known to be more inhomogeneous based on distorted cell conglomerates and partially inadequate blood supply and is therefore partially composed of necrotic tissue. Thus, the microperfusion and diffusion characteristics are significantly different compared with that in normal For the optimization, the parameter ranges for tumor and normal liver tissue (Table 2) were combined.
tissue. Consequently, the expected IVIM parameters and their ranges are different in pathologic lesions, and the presented optimal distributions may no longer be optimal for these cases and errors may increase.
Because the diffusion coefficient is more related to the high bvalues, tissue with a high diffusion coefficient could need more b-values in this region and/or more signal averages to increase signal to noise ratio and measured accuracy for a more reliable fit, although the error in the diffusion estimation is usually relatively low compared with that in the pseudodiffusion constant, which is approximately 2 to 3 times higher (Figs. 2, 3) . The pseudodiffusion constant is more related to the low (Fig. 4) . 19, 20 More parameter considerations can be found in Supplemental Digital Content 5, http://links.lww.com/RLI/A226.
Overall, the diffusion parameter D has the smallest relative error, followed by the perfusion fraction f and the pseudodiffusion D*. The The largest gain in error reduction is in the range when moving from 4 to 11 b-values (for example, see Figs. 2, 3) . Therefore, we would consider 11 b-values an absolute minimum. These findings are similar to previous work by Lemke et al and Jambor et al in healthy liver, kidney, and spleen. 13, 15 Dyvorne et al 14 on the other hand recommended a minimum of 4 b-values for their liver fibrosis study. Their D* reproducibility was, however, significantly worse compared with that of other studies. The authors claim that this could be related to the wider parameter range they allowed in their study. If the expected IVIM parameter range is very small, an optimized protocol could reduce the number of b-values even further. However, in tumor tissue, a larger parameter range is expected, and therefore more b-values need to be included.
With 16 b-values, the error is reduced even further (see also Figs. 2, 3) while the acquisition time is still reasonable. With the optimal calculated b-value distributions we, for example, showed that the mean relative error in normal liver tissue is less than 0.2 with 16 b-values (Fig. 2) . Therefore, we would recommend 16 b-values.
However, when analyzing inhomogeneous tumor tissue with the same reduced amount of (optimized) b-values, the mean relative error increased to 0.5. The results in Figure 3 show that (the mapped versions of ) the distributions proposed by Lemke et al are comparable to our optimized distributions and also have an increased error in tumor tissue compared with that in normal liver tissue. Therefore, when analyzing (inhomogeneous) tumor tissue, or multiple organs, large differences in IVIM parameters and reduced data quality have to be expected. These wide ranges in expected IVIM parameters make it hard to find optimal b-value distributions. In these cases, it recommends scanning as many b-values as time permits.
Although not all protocols available in the literature comparison were intended for IVIM or liver tumor analysis (Supplemental Digital Content 3, http://links.lww.com/RLI/A223), the results, presented in As mentioned previously, motion could play an important role in abdominal imaging. The larger relative error in tumor tissue compared with that in normal-appearing tissue could also be partially explained by motion and partial volume. Respiratory motion and cardiac and aortic pulsations cause the position of the tumor to change during scanning. 36 As a result, surrounding liver tissue could move in and out of the tumor ROIs and, in addition, because tumor tissue is often less homogeneous than liver tissue, motion in a tumor ROI could have a larger effect than motion inside a normal liver ROI when comparing IVIM parameter maps. Respiratory and cardiac gating could circumvent this problem, but it would roughly double the total IVIM acquisition time. Increasing the number of signal averages could improve the results, but often only by blurring the motion artifact. A better solution could be scanning duplicate b-values and rejecting data points that are affected by motion during postprocessing. This way, the increased scan time could lead to an increase in signal to noise, of course depending on the amount of data points that are not rejected. Instead of rejecting data points, one could also perform motion correction. As the high b-value images have only a limited amount of signal and are therefore difficult to register, one could scan in a different way, for example, alternating low b-value with high b-value scans. 37 Our study has some limitations. Repeatedly adding b-values to a set of optimal b-values does not necessarily lead to the best b-value set with the lowest cost. Testing all possible b-value combinations would be better; however, such computations are almost impossible due to the very high number of possible combinations. In addition, the mapping of the b-values, as found in literature, to the nearest b-value in our 25-b-value IVIM protocol could have an effect on the mean relative error, although the effect is expected to be minimal.
CONCLUSIONS
Including more b-values and applying an optimized b-value distribution significantly reduces errors in the IVIM parameter estimates, thereby increasing its accuracy.
This effect is even more pronounced in inhomogeneous tumor compared with that in normal liver tissue. However, when restrictions in acquisition time or patient-related factors apply, a minimum of 16 b-values should be considered for reliable results.
